Skip to main content

Table 3 Adverse events and serious adverse events up to day 28

From: Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis

 

Adverse events (N = 108)

Serious adverse events (N = 108)

n (%)

 

Anaemia

2 (1.9)

2 (1.9)

P. vivax malaria

1 (0.9)

Nausea

1 (0.9)